Boston Scientific Facing Slowing Sales, Earnings , 09.27.05, 3:27 PM ET Merrill Lynch downgraded shares of Boston Scientific (nyse: - - ) to 'neutral' from 'buy,' citing 'prolonged deceleration' for the medical device maker's sales and earnings. '
http://c.moreover.com/click/here.pl?r397694064
http://c.moreover.com/click/here.pl?r397694064
